Therapeutic schemes of denosumab in the treatment of giant cell tumor of bone - Protocol for a systematic review with meta-analysis
DOI:
https://doi.org/10.33448/rsd-v11i6.29110Keywords:
Bone Neoplasms; Denosumab; Evaluation of Results of Therapeutic Interventions; Giant Cell Tumor of Bone; Health Teaching; Systematic review.Abstract
The aim of this study is to evaluate the efficacy of different therapeutic regimens using denosumab in patients with giant cell tumor of bone (GCTB), regarding primary outcomes related to therapeutic response (lesion size, pain and function) and presentation to imaging exams, in addition to secondary outcomes related to age (in years) and tumor location, reduction or downgrade of surgical indication, local recurrence, presence of pulmonary metastases and therapeutic side effects. A systematic literature search will be carried out in the PubMed/MEDLINE, Embase (CAPES Journals), Science Direct/Elsevier, Scielo, Cochrane Library and clinical trial records (ClinicalTrials.gov and Registro Brasileiro de Ensaios Clínicos) databases; for exploration of grey literature, the Open Access Theses and Dissertations and the Biblioteca Digital Brasileira de Teses e Dissertações databases will be consulted. We will also conduct a "snowball" survey to identify additional eligible studies for full-text review. Two evaluators will select, extract and assess the risk of bias of the obtained data. If appropriate, a meta-analysis will be carried out, extracting data for the number of events and total patients to perform proportion meta-analysis using the R software, with the "meta" package (version 4.9–6), the "metaprop function" for aspect ratio data. The results of this review will provide convincing information on the efficacy of different therapeutic regimens using denosumab in GCTB, providing a reliable theoretical basis for the research that will follow.
References
Balke, M., Schremper, L., Gebert, C., Ahrens, H., Streitbuerger, A., Koehler, G., Hardes, J., & Gosheger, G. (2008). Giant cell tumor of bone: Treatment and outcome of 214 cases. Journal of cancer research and clinical oncology, 134(9), 969–978. https://doi.org/10.1007/s00432-008-0370-x
Baptista, P. P. R., Próspero, J. D., & Yonamine, E. S. (2001). Tumor de células gigantes. Revista Brasileira de ortopedia, 36(7), 239-144. https://cdn.publisher.gn1.link/rbo.org.br/pdf/36-6/2001_jul_07.pdf
Catalan, J., Fonte, A. C., Lusa, J. R. B., Oliveira, A. D., Melo, E. S., Justino Júnior, R. O., Min, T. T., Lima, A. C. M., & Gonçalves, C. M. (2006). Tumor de células gigantes ósseo: Aspectos clínicos e radiográficos de 115 casos. Radiologia brasileira, 39(2), 119-122. https://doi.org/10.1590/S0100-39842006000200009
de Mattos Brito Oliveira Viana, E., Batista, K. T., & Carneiro Junior, J. L. (2019). Inoperable giant cell tumor of the sacrum: Therapeutic options and pain control. Revista brasileira de ortopedia, 54(3), 347–352. https://doi.org/10.1055/s-0039-1692450
Deventer, N., Budny, T., Gosheger, G., Rachbauer, A., Puetzler, J., Theil, J. C., Kovtun, D., de Vaal, M., & Deventer, N. (2022). Giant cell tumor of bone: A single center study of 115 cases. Journal of bone oncology, 33, 100417. https://doi.org/10.1016/j.jbo.2022.100417
Guedes, A., Baptista, P. P. R., Santili, C., Yonamine, E. S., Garcia, H. R. P., & Martinez E. C. (2009). Wide resection and fibular transposition in the treatment of GCT on radius distal end. Acta ortopédica brasileira, 17(3), 171–181. https://doi.org/10.1590/S1413-78522009000300010
Guedes, A., Oliveira, M., Costa, F. M., & de Melo, A. S. (2021). Updating on Bone and Soft Tissue Sarcomas Staging. Revista brasileira de ortopedia, 56(4), 411–418. https://doi.org/10.1055/s-0040-1710331
Guedes, A., Oliveira, M., de Melo, A. S., & do Carmo, C. C. M (2021). Update in Imaging Evaluation of Bone and Soft Tissue Sarcomas. Revista brasileira de ortopedia. Advance online publication. https://doi.org/10.1055/s-0041-1736569
Higgins, J. P. T., Deeks J. J., & Altman, D. G. (2011). Imputing standard deviations for changes from baseline. In Higgins, J. P. T., & Green, S. (Eds.) Cochrane Handbook for Systematic Reviews of Interventions. The Cochrane Collaboration. https://handbook-5-1.cochrane.org/chapter_16/16_1_3_2_imputing_standard_deviations_for_changes_from_baseline.htm
Lazaretti, N. S., Dallagasperina, V. W., Villaroel, R. U., & Schlittler, L. A. (2010). Tumor de células gigantes de fémur distal com metástases pulmonares. Revista portuguesa de pneumologia (english edition), 16(2), 331–337. https://doi.org/10.1016/s2173-5115(10)70040-3
Lipplaa, A., Dijkstra, S., & Gelderblom, H. (2019). Challenges of denosumab in giant cell tumor of bone, and other giant cell-rich tumors of bone. Current opinion in oncology, 31(4), 329–335. https://doi.org/10.1097/CCO.0000000000000529
Luengo-Alonso, G., Mellado-Romero, M., Shemesh, S., Ramos-Pascua, L., & Pretell-Mazzini, J. (2019). Denosumab treatment for giant-cell tumor of bone: A systematic review of the literature. Archives of orthopaedic and trauma surgery, 139(10), 1339–1349. https://doi.org/10.1007/s00402-019-03167-x
Mendenhall, W. M., Zlotecki, R. A., Scarborough, M. T., Gibbs, C. P., & Mendenhall, N. P. (2006). Giant cell tumor of bone. American journal of clinical oncology : cancer clinical trials, 29(1), 96–99. https://doi.org/10.1097/01.coc.0000195089.11620.b7
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & PRISMA Group (2010). Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. International journal of surgery (London, England), 8(5), 336–341. https://doi.org/10.1016/j.ijsu.2010.02.007
NIH. (2022, April 3). Study Quality Assessment Tools. https://www.nhlbi.nih.gov/health-topics/study-quality-assessment-tools
Ouzzani, M., Hammady, H., Fedorowicz, Z., & Elmagarmid, A. (2016). Rayyan-a web and mobile app for systematic reviews. Systematic reviews, 5(1), 210. https://doi.org/10.1186/s13643-016-0384-4
Page, M. J., McKenzie, J. E., Bossuyt, P. M., Boutron, I., Hoffmann, T. C., Mulrow, C. D., Shamseer, L., Tetzlaff, J. M., Akl, E. A., Brennan, S. E., Chou, R., Glanville, J., Grimshaw, J. M., Hróbjartsson, A., Lalu, M. M., Li, T., Loder, E. W., Mayo-Wilson, E., McDonald, S., McGuinness, L. A., & Moher, D. (2021). The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ (Clinical research ed.), 372, n71. https://doi.org/10.1136/bmj.n71
Rutkowski, P., Gaston, L., Borkowska, A., Stacchiotti, S., Gelderblom, H., Baldi, G. G., Palmerini, E., Casali, P., Gronchi, A., Parry, M., Campanacci, D. A., Scoccianti, G., Wagrodzki, M., Ferrari, S., Dijkstra, S., Pieńkowski, A., & Grimer, R. (2018). Denosumab treatment of inoperable or locally advanced giant cell tumor of bone - Multicenter analysis outside clinical trial. European journal of surgical oncology: the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology, 44(9), 1384–1390. https://doi.org/10.1016/j.ejso.2018.03.020
Singh, A. S., Chawla, N. S., & Chawla, S. P. (2015). Giant-cell tumor of bone: treatment options and role of denosumab. Biologics: targets & therapy, 9, 69–74. https://doi.org/10.2147/BTT.S57359
Sobti, A., Agrawal, P., Agarwala, S., & Agarwal, M. (2016). Giant Cell Tumor of Bone - An Overview. The archives of bone and joint surgery, 4(1), 2–9.
van der Heijden, L., Dijkstra, P., Blay, J. Y., & Gelderblom, H. (2017). Giant cell tumour of bone in the denosumab era. European journal of cancer (Oxford, England: 1990), 77, 75–83. https://doi.org/10.1016/j.ejca.2017.02.021
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Bruno Garcia Barreto; Cláudio Santili; Alex Guedes; Cláudio Luiz da Silva Lima Paz; Fernando Delmonte Moreira; Enilton Santana Ribeiro de Mattos
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
